Skip to content

Successful treatment of nightmares may reduce psychotic symptoms in schizophrenia.

Mary V. Seeman

World Journal of Psychiatry September 20, 2018 DOI: 10.5498/wjp.v8.i3.75 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Commentary Peer reviewed
Intervention Image Rehearsal Therapy
Topics Dreaming
Keywords Sleep Psychosis Nightmares Image rehearsal therapy Nightmare-inducing drugs
Key points Argues that nightmares in schizophrenia are underrecognized and undertreated, and that Image Rehearsal Therapy and other interventions effective in non-schizophrenia populations should be considered early in psychotic illness as an adjunct to standard treatment.

Abstract

Nightmares occur more frequently in patients with schizophrenia than they do in the general population. Nightmares are profoundly distressing and may exacerbate daytime psychotic symptoms and undermine day-to-day function. Clinicians do not often ask about nightmares in the context of psychotic illness and patients may underreport them or, if nightmares are reported, they may be disregarded; it may be assumed that they will disappear with antipsychotic medication and that they do not, therefore, require separate intervention. This is a missed opportunity because Image Rehearsal Therapy, among other psychological and pharmacological interventions, has proven effective for nightmares in non-schizophrenia populations and should be considered at an early stage of psychotic illness as an important adjunct to standard treatment. There is active ongoing research in this field, which will undoubtedly benefit patients with schizophrenia in the future.

Citations in the library

Explore topics